Deutsche Bank’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.3M Sell
605,013
-287,846
-32% -$6.78M 0.01% 913
2025
Q1
$21.4M Buy
892,859
+82,483
+10% +$1.98M 0.01% 805
2024
Q4
$34.3M Buy
810,376
+43,832
+6% +$1.85M 0.01% 721
2024
Q3
$33.9M Buy
766,544
+131,184
+21% +$5.8M 0.01% 705
2024
Q2
$23M Sell
635,360
-1,634
-0.3% -$59.1K 0.01% 777
2024
Q1
$27.5M Buy
636,994
+3,309
+0.5% +$143K 0.01% 716
2023
Q4
$9.75M Buy
633,685
+617,654
+3,853% +$9.5M 0.01% 1006
2023
Q3
$220K Buy
16,031
+2,289
+17% +$31.4K ﹤0.01% 2701
2023
Q2
$221K Sell
13,742
-208
-1% -$3.34K ﹤0.01% 2826
2023
Q1
$108K Buy
13,950
+7,602
+120% +$59K ﹤0.01% 3284
2022
Q4
$123K Buy
6,348
+92
+1% +$1.78K ﹤0.01% 3218
2022
Q3
$133K Sell
6,256
-2,317
-27% -$49.3K ﹤0.01% 3159
2022
Q2
$116K Buy
8,573
+469
+6% +$6.35K ﹤0.01% 3431
2022
Q1
$191K Buy
8,104
+2,091
+35% +$49.3K ﹤0.01% 3274
2021
Q4
$161K Buy
6,013
+1,945
+48% +$52.1K ﹤0.01% 3442
2021
Q3
$71K Buy
+4,068
New +$71K ﹤0.01% 3920